Short Communication
Impact of the COVID-19 pandemic on the standard of care for patients with lysosomal storage diseases: A survey of healthcare professionals in the Fabry, Gaucher, and Hunter Outcome Survey registries

https://doi.org/10.1016/j.ymgmr.2021.100788Get rights and content
Under a Creative Commons license
open access

Highlights

  • The COVID-19 pandemic has changed how physicians and patients interact.

  • A survey explored the impact of these changes on the care of patients with lysosomal storage diseases.

  • 88% of respondents noted that the pandemic had affected standards of care.

  • Increased need for personalized care and direct communication was noted.

  • Increased reliance on telemedicine was also highlighted.

Abstract

The impact of the COVID-19 pandemic on the standards of care of patients with lysosomal storage diseases and the needs of their healthcare providers were explored using a 12-question survey. Overall, 80/91 respondents (88%) indicated that the pandemic had negatively affected standards of care. With increased reliance on telemedicine, the respondents highlighted the need for a personalized approach to care, direct and frequent communication with patients, and greater involvement of patients and caregivers.

Keywords

Lysosomal storage disease
Fabry Outcome Survey
Gaucher Outcome Survey
Hunter Outcome Survey
COVID-19
Standard of care

Abbreviations

COVID-19
coronavirus disease 2019
ERT
enzyme replacement therapy
FOS
Fabry Outcome Survey
GOS
Gaucher Outcome Survey
HCP
healthcare professional
HOS
Hunter Outcome Survey
IT
information technology
LSD
lysosomal storage disease
MPS II
mucopolysaccharidosis II

Cited by (0)